Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage

A Karimian, Y Ahmadi, B Yousefi - DNA repair, 2016 - Elsevier
An appropriate control over cell cycle progression depends on many factors. Cyclin-
dependent kinase (CDK) inhibitor p21 (also known as p21 WAF1/Cip1) is one of these …

AMP‐activated protein kinase: a key regulator of energy balance with many roles in human disease

D Grahame Hardie - Journal of internal medicine, 2014 - Wiley Online Library
The AMP‐activated protein kinase (AMPK) is a sensor of cellular energy status that
regulates cellular and whole‐body energy balance. A recently reported crystal structure has …

STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma

F Skoulidis, ME Goldberg, DM Greenawalt… - Cancer …, 2018 - aacrjournals.org
KRAS is the most common oncogenic driver in lung adenocarcinoma (LUAC). We previously
reported that STK11/LKB1 (KL) or TP53 (KP) comutations define distinct subgroups of KRAS …

LKB1 loss links serine metabolism to DNA methylation and tumorigenesis

F Kottakis, BN Nicolay, A Roumane, R Karnik, H Gu… - Nature, 2016 - nature.com
Intermediary metabolism generates substrates for chromatin modification, enabling the
potential coupling of metabolic and epigenetic states. Here we identify a network linking …

[HTML][HTML] Monitoring tumorigenesis and senescence in vivo with a p16INK4a-luciferase model

CE Burd, JA Sorrentino, KS Clark, DB Darr… - Cell, 2013 - cell.com
Monitoring cancer and aging in vivo remains experimentally challenging. Here, we describe
a luciferase knockin mouse (p16 LUC), which faithfully reports expression of p16 INK4a, a …

LKB1 and AMPK and the cancer-metabolism link-ten years after

DG Hardie, DR Alessi - BMC biology, 2013 - Springer
The identification of a complex containing the tumor suppressor LKB1 as the critical
upstream kinase required for the activation of AMP-activated protein kinase (AMPK) by …

Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma

CE Burd, W Liu, MV Huynh, MA Waqas… - Cancer …, 2014 - aacrjournals.org
Abstract NRAS mutation at codons 12, 13, or 61 is associated with transformation; yet, in
melanoma, such alterations are nearly exclusive to codon 61. Here, we compared the …

Pathways and therapeutic targets in melanoma

E Shtivelman, MA Davies, P Hwu, J Yang… - …, 2014 - pmc.ncbi.nlm.nih.gov
This review aims to summarize the current knowledge of molecular pathways and their
clinical relevance in melanoma. Metastatic melanoma was a grim diagnosis, but in recent …

Metformin: An anti-diabetic drug to fight cancer

M Daugan, AD Wojcicki, B d'Hayer, V Boudy - Pharmacological research, 2016 - Elsevier
Since epidemiologic data have highlighted the positive effects of metformin to reduce cancer
incidence and mortality, many in vitro and in vivo studies as well as a large number of …

Tumor‐propagating cells and Y ap/T az activity contribute to lung tumor progression and metastasis

AN Lau, SJ Curtis, CM Fillmore, SP Rowbotham… - The EMBO …, 2014 - embopress.org
Metastasis is the leading cause of morbidity for lung cancer patients. Here we demonstrate
that murine tumor propagating cells (TPC s) with the markers S ca1 and CD 24 are enriched …